Compare OVID & BMHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVID | BMHL |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.5M | 95.2M |
| IPO Year | 2017 | 2025 |
| Metric | OVID | BMHL |
|---|---|---|
| Price | $1.60 | $3.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $3.40 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 4.2K |
| Earning Date | 03-10-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.50 |
| EPS | N/A | ★ 0.05 |
| Revenue | $6,610,000.00 | ★ $6,873,097.00 |
| Revenue This Year | $1,077.56 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $67.77 |
| Revenue Growth | ★ 945.89 | 66.02 |
| 52 Week Low | $0.24 | $2.72 |
| 52 Week High | $2.01 | $4.49 |
| Indicator | OVID | BMHL |
|---|---|---|
| Relative Strength Index (RSI) | 42.14 | 51.01 |
| Support Level | $1.40 | $3.20 |
| Resistance Level | $1.61 | $3.72 |
| Average True Range (ATR) | 0.12 | 0.17 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 15.91 | 69.70 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Bluemount Holdings Ltd through its operating subsidiaries, it is a Hong Kong-based consulting and advisory and financial services provider, as well as trader of commodities such as luxury timepieces. The financial services includes underwriting and placing services, securities dealing and brokerage services, and asset management services. It provides comprehensive consulting and advisory services on business development strategies to its diverse clientele. Generally, the company provides consulting and advisory business for the following segments: Corporate Finance; and Strategic Communications.